Oral 17β-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size

This publication has 36 references indexed in Scilit:

• Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women
  Published by Wolters Kluwer Health ,1998
• Effect of Estrogen on Very Low Density Lipoprotein and Low Density Lipoprotein Subclass Metabolism in Postmenopausal Women
  Journal of Clinical Endocrinology & Metabolism, 1997
• Effect of 17β-Estradiol on Plasma Lipids and LDL Oxidation in Postmenopausal Women With Type II Diabetes Mellitus
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens
  Atherosclerosis, 1996
• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial
  JAMA, 1995
• Characterization of low-density lipoprotein subclasses
  Current Opinion in Lipidology, 1994
• Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations
  Archives of internal medicine (1960), 1994
• Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Change in LDL particle size is associated with change in plasma triglyceride concentration.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991